| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-10 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.32 | 3e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 7e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |